Smoking modulates interferon-γ expression in the gingival tissue of patients with chronic periodontitis

European Journal of Oral Sciences

Volumn 114, Issue 5, 2006, Pages 403-408

  César Neto, João B ^a   Duarte, Poliana M ^a   De Oliveira, Maria Claudia G ^a   Casati, Márcio Z ^a   Tambeli, Claudia H ^a   Parada, Carlos A ^b   Sallum, Enilson A ^a   Nociti Jr , Francisco H ^a,c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Cytokines; Periodontal disease; Smoking

Indexed keywords

ANTIVIRUS AGENT; GAMMA INTERFERON; MESSENGER RNA;

ADULT; ARTICLE; CHRONIC DISEASE; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; GINGIVA; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PERIODONTITIS; SMOKING;

ADULT; ANTIVIRAL AGENTS; CHRONIC DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; GINGIVA; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA; MALE; MIDDLE AGED; PERIODONTITIS; RNA, MESSENGER; SMOKING;

EID: 33749534676     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2006.00397.x     Document Type: Article

References (36)

1. PAGE RC, OFFENBACHER S, SCHROEDER HE, SEYMOUR GJ, KORNMAN KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontology 2000 1997; 14: 216-248.
2. GEMMELL E, SEYMOUR GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontology 2000 2004; 35: 21-41.
3. SIMONET WS, LACEY DL, DUNSTAN CR, KELLEY M, CHANG MS, LUTHY R, NGUYEN HQ, WOODEN S, BENNETT L, BOONE T, SHIMAMOTO G, DEROSE M, ELLIOTT R, COLOMBERO A, TAN HL, TRAIL G, SULLIVAN J, DAVY E, BUCAY N, RENSHAW-GEGG L, HUGHES TM, HILL D, PATTISON W, CAMPBELL P, SANDER S, VAN G, TARPLEY J, DERBY P, LEE R, BOYLE WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319.
4. TENG YT, NGUYEN H, GAO X, KONG YY, GORCZYNSKI RM, SINGH B, ELLEN RP, PENNINGER JM. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000; 106: R59-R67.
5. KONG YY, FEIGE U, SAROSI I, BOLON B, TAFURI A, MORONY S, CAPPARELLI C, LI J, ELLIOTT R, MCCABE S, WONG T, CAMPAGNUOLO G, MORAN E, BOGOCH ER, VAN G, NGUYEN LT, OHASHI PS, LACEY DL, FISH E, BOYLE WJ, PENNINGER JM. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402: 304-308.
6. THEILL LE, BOYLE WJ, PENNINGER JM. RANK-L and RANK. T cell, bone loss and mammalian evolution. Annu Rev Immunol 2002; 20: 795-823.
7. HOFBAUER LC, SCHOPPET M. Clinical implication of the osteoprotegerin/ RANKL/RANK system for bone and vascular diseases. JAMA 2004; 28: 490-495.
8. BROWN JM, ZHANG J, KELLER ET. OPG, RANKL and RANK in cancer metastasis: expression and regulation. Cancer Treat Res 2004; 118: 149-172.
9. + myelopoiesis. Arthritis Res Ther 2004; 6: R220-R231.
10. TAKAYANAGI H, OGASAWARA K, HIDA S, CHIBA T, MURATA S, SATO K, TAKAOKA A, YOKOCHI T, ODA H, TANAKA K, NAKAMURA K, TANIGUCHI T. T cell mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 2000; 408: 600-605.
11. BAKER PJ, DIXON M, EVANS RT, DUFOUR L, JOHNSON E, ROOPENIAN DC. CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999; 67: 2804-2809.
12. KAWAI T, EISEN-LEV R, SEKI M, EASTCOTT JW, WILSON ME, TAUBMAN MA. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 2000; 164: 2102-2109.
13. VALVERDE P, KAWAI T, TAUBMAN MA. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J Bone Miner Res 2004; 19: 155-164.
14. ELLIS TN, BEAMAN BL. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 2004; 112: 2-12.
15. HEROLD KC. Achieving antigen-specific immune regulation. J Clin Invest 2004; 113: 346-349.
16. BERGSTROM J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol 1989; 17: 245-247.
17. BERGSTROM J, ELIASSON S, DOCK J. A 10-year prospective study of tobacco smoking and periodontal health. J Periodontol 2000; 71: 1338-1347.
18. BOSTROM L, LINDER LE, BERGSTROM J. Clinical expression of TNF-alpha in smoking-associated periodontal disease. J Clin Periodontol 1998; 25: 767-773.
19. ERDEMIR EO, DURAN I, HALILOGLU S. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis. J Clin Periodontol 2004; 31: 99-104.
20. FREDRIKSSON M, BERGSTROM K, ASMAN B. IL-8 and TNF-alpha from peripheral neutrophils and acute-phase proteins in periodontitis. J Clin Periodontol 2002; 29: 123-128.
21. GIANNOPOULOU C, KAMMA JJ, MOMBELLI A. Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. J Clin Periodontol 2003; 30: 145-153.
22. GIANNOPOULOU C, CAPPUYNS I, MOMBELLI A. Effect of smoking on gingival crevicular fluid cytokine profile during experimental gingivitis. J Clin Periodontol 2003; 30: 996-1002.
23. KAMMA JJ, GIANNOPOULOU C, VASDEKIS VG, MOMBELLI A. Cytokine profile in gingival crevicular fluid of aggressive periodontitis: influence of smoking and stress. J Clin Periodontol 2004; 31: 894-902.
24. RAWLINSON A, GRUMMITT JM, WALSH TF, IAN DOUGLAS CW. Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. J Clin Periodontol 2003; 30: 42-48.
25. SODER B, JIN LJ, WICKHOLM S. Granulocyte elastase, matrix metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 2002; 29: 384-391.
26. SAFIEH-GARABEDIAN B, POOLE S, ALLCHORNE A, WINTER J, WOOLF CJ. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1995; 115: 1265-1275.
27. BERNZWEIG E, PAYNE JB, REINHARDT RA, DYER JK, PATIL KD. Nicotine and smokeless tobacco effects on gingival and peripheral blood mononuclear cells. J Clin Periodontol 1998; 25: 246-252.
28. PAYNE JB, JOHNSON GK, REINHARDT RA, DYER JK, MAZE CA, DUNNING DG. Nicotine effects on PGE2 and IL-1 beta release by LPS-treated human monocytes. J Periodontal Res 1996; 31: 99-104.
29. BOSTROM L, LINDER LE, BERGSTROM J. Smoking and cervicular fluid levels of IL-6 and TNF-alpha in periodontal disease. J Clin Periodontol 1999; 26: 352-357.
30. BOSTROM L, LINDER LE, BERGSTROM J. Smoking and GCF levels of IL-1beta and IL-1ra in periodontal disease. J Clin Periodontol 2000; 27: 250-255.
31. MOROZUMI T, KUBOTA T, SUGITA N, ITAGAKI M, YOSHIE H. Alterations of gene expression in human neutrophils induced by smoking cessation. J Clin Periodontol 2004; 31: 1110-1116.
32. FRASER DA, LOOS BG, BOMAN U, VAN WINKELHOFF AJ, VAN DER VELDEN U, SCHENCK K, DEMBIC Z. Polymorphisms in an interferon-gamma receptor-1 gene marker and susceptibility to periodontitis. Acta Odontol Scand 2003; 61: 297-302.
33. GORSKA R, GREGOREK H, KOWALSKI J, LASKUS-PERENDYK A, SYCZEWSKA M, MADALINSKI K. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 2003; 30: 1046-1052.
34. TENG YT, MAHAMED D, SINGH B. Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo. Infect Immun 2005; 73: 3453-3461.
35. EBERSOLE JL, TAUBMAN MA. The protective nature of host responses in periodontal diseases. Periodontology 2000 1994; 5: 112-141.
36. KOTAKE S, NANKE Y, MOGI M, KAWAMOTO M, FURUYA T, YAGO T, KOBASHIGAWA T, TOGARI A, KAMATANI N. IFN-γ-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol 2005; 35: 3353-3363.